NPB:NYSENorthpointe Bancshares, Inc. Analysis
Data as of 2026-07-17 - not real-time
$19.16
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Northpointe Bancshares is trading at $19.16, comfortably above its 20‑day SMA (≈$18.61) and 50‑day SMA (≈$17.93), signaling a bullish trend despite a modest bearish tilt in the MACD histogram. The RSI sits at 61, indicating healthy momentum without being overbought, while volume has been trending down, suggesting a potential short‑term softening as the stock approaches its resistance near $19.71. Valuation metrics are compelling: a trailing P/E of about 8x is well below the industry average of ~18x, and the price‑to‑book of 1.12 hovers just above book value, pointing to an undervalued position with an upside potential of roughly 12% versus consensus target prices around $22.
Fundamentally, NPB posted 27.9% revenue growth and maintains a solid operating margin of 46%, translating to a 35% profit margin and a respectable ROE of 15%. The dividend of $0.025 per share yields just over 0.5% with a payout ratio under 5%, indicating strong sustainability. Cash on hand (~$488 M) comfortably covers current obligations, though total debt exceeds $1.7 B, warranting monitoring. Recent material news is limited to a routine earnings release announcement and a dividend declaration, providing no immediate catalyst but underscoring stable shareholder communication.
Fundamentally, NPB posted 27.9% revenue growth and maintains a solid operating margin of 46%, translating to a 35% profit margin and a respectable ROE of 15%. The dividend of $0.025 per share yields just over 0.5% with a payout ratio under 5%, indicating strong sustainability. Cash on hand (~$488 M) comfortably covers current obligations, though total debt exceeds $1.7 B, warranting monitoring. Recent material news is limited to a routine earnings release announcement and a dividend declaration, providing no immediate catalyst but underscoring stable shareholder communication.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price nearing resistance at $19.71
- Decreasing volume trend
- Bearish MACD histogram signal
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant revenue growth (≈28%)
- Undervalued valuation relative to peers
- Low beta (≈0.78) indicating defensive profile
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend with low payout ratio
- Strong operating margins and ROE
- Potential sector recovery for regional banks
Key Metrics & Analysis
Financial Health
Revenue Growth27.90%
Profit Margin35.11%
P/E Ratio8.2
ROE15.01%
ROA1.33%
P/B Ratio1.1
Op. Cash Flow$27.6M
Industry P/E18.0
Technical Analysis
TrendBullish
RSI61.2
Support$17.63
Resistance$19.71
MA 20$18.61
MA 50$17.93
MA 200$17.52
MACDBearish
VolumeDecreasing
Fear & Greed Index88.73
Valuation
Target Price$21.42
Upside/Downside11.78%
GradeUndervalued
TypeBlend
Dividend Yield0.52%
Risk Assessment
Beta0.78
Volatility27.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.